panepidem
result
infect
novel
coronaviru
also
known
sever
acut
respiratori
current
sourc
public
health
concern
worldwid
howev
treatment
infect
clinic
challeng
mani
patient
importantli
third
fatal
coronaviru
emerg
past
two
decad
follow
sarscov
middl
east
respiratori
syndrom
mer
cov
number
confirm
case
infect
relat
death
still
rise
march
confirm
case
death
mainland
china
correspond
total
crude
mortal
mortal
higher
sever
ill
patient
estim
percentag
sever
patient
treatment
strategi
urgent
need
hypercytokinemia
also
known
cytokin
storm
frequent
occur
featur
sever
infect
sar
mer
influenza
influenza
associ
diseas
sever
predictor
mortal
studi
sar
shown
elev
level
cytokineschemokin
interleukin
il
interferon
ifn
c
ifncinduc
protein
monocyt
chemoattract
associ
inflamm
extens
damag
lung
elev
level
ifnc
tumor
necrosi
factora
tnfa
also
featur
merscov
infect
similarli
serum
level
ifnc
monokin
induc
ifnc
mig
higher
influenzainfect
patient
healthi
individu
moreov
patient
influenza
infect
higher
level
cytokin
chemokin
hepatocyt
growth
factor
macrophag
migrat
inhibitori
factor
mig
stem
cell
factor
stem
cell
growth
factorb
notabl
cytokineschemokin
proinflammatori
previou
studi
reveal
high
level
proinflammatori
cytokineschemokin
eg
granulocytecoloni
stimul
factor
gcsf
macrophag
inflammatori
protein
tnfa
sever
critic
ill
patient
infect
furthermor
presenc
cytokin
storm
correl
diseas
sever
studi
reveal
lethal
coronaviru
influenza
viru
relat
induct
excess
aberr
immun
respons
associ
sever
lung
patholog
frequent
fatal
consequ
therefor
curb
overt
inflammatori
respons
induc
may
essenti
reduc
mortal
among
sever
critic
ill
patient
infect
howev
clinic
manag
sever
patient
infect
sar
mer
reveal
corticosteroid
therapi
reduc
mortal
contrast
led
delay
viral
clearanc
tertiari
hospit
hubei
provinc
china
system
corticosteroid
use
treat
sever
ill
patient
infect
exhibit
signific
acut
pulmonari
progress
imag
examin
howev
limit
experi
shown
strategi
result
signific
improv
patient
sarscovrel
acut
respiratori
distress
syndrom
cytokinestormtarget
therapi
recommend
treat
sever
pulmonari
failur
secondari
excess
inflammatori
respons
studi
show
cytokin
chemokin
clearanc
achiev
use
artificialliv
bloodpurif
system
consist
bloodpurif
modul
plasma
exchang
plasma
absorpt
andor
hemoplasma
filtrat
artificialliv
bloodpurif
system
use
treat
patient
sever
influenza
infect
confirm
cytokin
storm
rapidli
deterior
condit
posit
result
demonstr
term
remark
reduc
level
cytokineschemokin
basic
fibroblast
growth
factor
fgf
gcsf
granulocytemacrophagecolonystimul
factor
ifnc
receptor
antagonist
plateletderiv
growth
factorbb
regul
upon
activ
normal
cell
express
secret
rant
tnfa
vascular
endotheli
growth
factor
encourag
result
achiev
first
session
artificialliv
bloodpurif
therapi
maintain
thereaft
experi
gain
treatment
critic
ill
patient
influenza
infect
cytokin
storm
reveal
high
efficaci
plasmaexchang
modul
artificialliv
bloodpurif
system
base
extent
cytokin
clearanc
result
consist
abil
plasma
exchang
clear
larg
molecul
blood
howev
treatment
critic
ill
patient
influenza
infect
limit
cytokin
clearanc
use
continu
venoven
hemofiltr
cvvh
modul
slight
increas
cytokinechemokin
level
may
reflect
abil
cvvh
modul
elimin
inflammatori
cytokin
clearanc
rate
slower
cytokin
releas
well
ineffect
clearanc
proteinbound
cytokin
hemofiltr
addit
scaveng
inflammatori
mediat
combin
plasma
exchang
cvvh
modul
artificialliv
bloodpurif
system
improv
manag
metabol
disord
fluid
overload
cardiovascular
dysfunct
given
demonstr
efficaci
cytokinestormtarget
rescu
therapi
sever
critic
ill
patient
influenza
viru
infect
artificialliv
blood
purif
may
effect
treat
sever
critic
ill
patient
infect
similarli
target
cytokin
storm
fig
artificialliv
bloodpurif
system
appli
zhejiang
provinc
china
show
good
prognosi
treatment
sever
critic
ill
patient
cytokin
storm
base
abovedescrib
evid
expert
consensu
applic
artificialliv
bloodpurif
system
treatment
sever
recent
releas
work
recommend
artificialliv
blood
purif
treatment
patient
infect
exhibit
cytokin
storm
rapid
diseas
progress
confirm
lung
imag
similar
recommend
made
guidelin
diagnosi
treatment
version
expert
consensu
report
cite
follow
indic
artificialliv
bloodpurif
therapi
sever
critic
ill
patient
infect
plasma
concentr
blood
inflammatori
factor
fivefold
upper
limit
normal
daili
increas
onefold
rapid
daili
progress
lung
involv
base
lung
imag
comput
tomographi
xray
comorbid
requir
artificialliv
bloodpurif
therapi
note
condit
must
met
simultan
wherea
condit
alon
suffici
treatment
implement
investig
may
conduct
near
futur
consid
follow
aspect
first
need
multicent
clinic
studi
anticytokinestorm
target
therapi
novel
artificialliv
bloodpurif
system
ie
li
artifici
liver
system
lial
demonstr
abil
clear
proinflammatori
cytokin
eg
tnfa
second
investig
need
regard
key
pathway
immun
cell
type
involv
cytokin
storm
onset
benefit
understand
artificialliv
support
system
treatment
allevi
cytokin
storm
revers
diseas
process
patient
sever
infect
rebalanc
immun
system
act
anticytokinestorm
target
therapi
artificialliv
bloodpurif
system
hold
excel
potenti
fig
artificialliv
bloodpurif
system
elimin
inflammatori
cytokineschemokin
allevi
cytokinestorminduc
damag
infect
reduc
mortal
sever
critic
ill
patient
infect
author
declar
known
compet
financi
interest
person
relationship
could
appear
influenc
work
report
paper
